Belite Bio (BLTE) Market Cap to FCF (2022 - 2026)

Belite Bio (BLTE) Market Cap to FCF (2022 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Market Cap to FCF
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-885,353.94
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-49,404.47
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	378.80
4	NuCana	279.75 Bn	279.75 Bn	-	1.44 Mn
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	32.41
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	16.48
7	Belite Bio	62.51 Bn	62.51 Bn	-	-6,019.45
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-35.26
10	Alnylam Pharmaceuticals	35.71 Bn	32.70 Bn	959.66 Mn	55.51

Download Data